HKSE - Delayed Quote • HKD
Biosino Bio-Technology and Science Incorporation (8247.HK)
At close: April 24 at 3:15 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
289,073.000
289,073.000
373,071.000
348,225.000
325,256.000
Cost of Revenue
161,708.000
161,708.000
226,794.000
204,633.000
214,695.000
Gross Profit
127,365.000
127,365.000
146,277.000
143,592.000
110,561.000
Operating Expense
145,352.000
145,352.000
123,642.000
128,329.000
119,355.000
Operating Income
-17,987.000
-17,987.000
22,635.000
15,263.000
-8,794.000
Net Non Operating Interest Income Expense
-6,072.000
-6,072.000
-6,482.000
-10,346.000
-412.000
Pretax Income
-17,613.000
-17,613.000
18,516.000
6,407.000
2,155.000
Tax Provision
1,628.000
1,628.000
4,314.000
3,247.000
2,861.000
Net Income Common Stockholders
-11,648.000
-11,648.000
8,106.000
-1,140.000
2,718.000
Diluted NI Available to Com Stockholders
-11,648.000
-11,648.000
8,106.000
-1,140.000
2,718.000
Basic EPS
-0.08
--
0.06
-0.01
0.02
Diluted EPS
-0.08
--
0.06
-0.01
0.02
Basic Average Shares
144,707.176
--
144,707.176
144,707.176
144,707.176
Diluted Average Shares
144,707.176
--
144,707.176
144,707.176
144,707.176
Total Expenses
307,060.000
307,060.000
350,436.000
332,962.000
334,050.000
Net Income from Continuing & Discontinued Operation
-11,648.000
-11,648.000
8,106.000
-1,140.000
2,718.000
Normalized Income
-11,114.000
-11,114.000
8,255.380
-1,043.250
-4,195.500
Interest Income
326.000
326.000
335.000
219.000
10,908.000
Interest Expense
6,398.000
6,398.000
6,817.000
10,565.000
11,320.000
Net Interest Income
-6,072.000
-6,072.000
-6,482.000
-10,346.000
-412.000
EBIT
-11,215.000
-11,215.000
25,333.000
16,972.000
13,475.000
EBITDA
9,142.000
9,142.000
49,662.000
44,900.000
38,768.000
Reconciled Cost of Revenue
161,708.000
161,708.000
226,794.000
204,633.000
214,695.000
Reconciled Depreciation
20,357.000
20,357.000
24,329.000
27,928.000
25,293.000
Net Income from Continuing Operation Net Minority Interest
-11,648.000
-11,648.000
8,106.000
-1,140.000
2,718.000
Total Unusual Items Excluding Goodwill
-712.000
-712.000
-194.000
-129.000
9,218.000
Total Unusual Items
-712.000
-712.000
-194.000
-129.000
9,218.000
Normalized EBITDA
9,854.000
9,854.000
49,856.000
45,029.000
29,550.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
-178.000
-178.000
-44.620
-32.250
2,304.500
12/31/2020 - 2/27/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade